Quell Therapeutics Limited
https://quell-tx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Quell Therapeutics Limited
Downturn Hit UK Biotech In 2023 But New Pension Funds Could Fuel Growth
Funding for UK biotechs shrank again last year but sector leaders see hope of green shoots in 2024.
Can AstraZeneca Sustain Sector-Beating Growth? Its Buying Spree Could Help
AstraZeneca has maintained sector-beating growth for five years, but is looking to a new wave of bolt-on acquisitions and licensing deals to sustain that trajectory beyond 2030.
Eisai And Eli Lilly Triumph At The 19th Annual Scrip Awards
Eisai and Lilly were the biggest winners at the 19th Annual Scrip Awards in a glittering ceremony at the Dorchester in London’s Mayfair, hosted by the actor and comedian Jon Culshaw.
Investors Impressed With Dualyx Tregs Plans
The proceeds from the series A will be used to progress Dualyx’s preclinical program DT-001, which targets "the highly attractive TNF receptor 2 (TNFR2), widely regarded as a master control switch in immune modulation."
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice